Cleared Traditional

K760017 - CONSIOUS SEDATION (ANALOR P-76) (FDA 510(k) Clearance)

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K760017 · Mckesson Corp. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1976
Decision
39d
Days
Class 2
Risk

K760017 is an FDA 510(k) clearance for the CONSIOUS SEDATION (ANALOR P-76). Classified as Mixer, Breathing Gases, Anesthesia Inhalation (product code BZR), Class II - Special Controls.

Submitted by Mckesson Corp. (Mchenry, US). The FDA issued a Cleared decision on July 20, 1976 after a review of 39 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5330 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Mckesson Corp. devices

Submission Details

510(k) Number K760017 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 11, 1976
Decision Date July 20, 1976
Days to Decision 39 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
100d faster than avg
Panel avg: 139d · This submission: 39d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code BZR Mixer, Breathing Gases, Anesthesia Inhalation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BZR Mixer, Breathing Gases, Anesthesia Inhalation

All 54
Devices cleared under the same product code (BZR) and FDA review panel - the closest regulatory comparables to K760017.
F&P Optiflow Air/Oxygen Flow Source
K243917 · Fisher &Paykel Healthcare , Ltd. · Jul 2025
Midas Flowmeter
K241465 · Parker Hannifin Corporation · Sep 2024
Maxtec MaxBlend2+p
K231895 · Maxtec, LLC · Dec 2023
FlowStar Analog Mixer Flowmeter
K230987 · Baldus Sedation GmbH & Co. KG · Sep 2023
FlowStar Touch Digital Mixer Flowmeter
K222794 · Baldus Sedation GmbH & Co. KG · Jul 2023
Quality Mix Blender, Oxymixer
K221494 · Dehas Medical Systems GmbH · Jan 2023